Online Medical Education

Gain CME credit and insightful information by registering for our newest courses or search content by category.

Our Newest Courses

2020 Virtual Evolution

Evolution is Changing Paradigms for Women Treating Cancer. It is an innovative virtual conference presented from a female perspective and designed to incorporate sessions on professional and personal wellness.

2020 Virtual ESMO Review

The 2020 Virtual ESMO Review will be a condensed review of the global meeting held earlier in October and will give healthcare providers the opportunity to learn about the latest advances in oncology and translate science into better patient care. This meeting will facilitate the exchange and debate of translational cancer science in a virtual format.

Diversity in Cancer Care

There is a growing appreciation for diversity in the context of equality and equity in medicine. There are far too few educational programs that consider gender, race and ethnicity, and sexual orientation in the development and design of the curriculum, presenters, and intended audiences.

Health care teams should be focused on an inter-professional and interdisciplinary model that values the contributions of a range of perspectives in improving patient outcomes—including patient advocacy stakeholders. This program is designed to elevate and highlight the power of diversity and the goals of equity and equality in the cancer care team and will present both academic and thematic topics.

#LCSM Advances | Immunotherapy and the Adjuvant Use of Osimertinib

Our panel of medical experts – Dr. Millie Das, Dr. Gilberto Lopes, Dr. Shayma Kazmi, and Dr. Ravi Salgia– plus lung cancer patient advocate, Lindi Campbell discuss immunotherapy and the adjuvant use of osimertinib. 

Breast Cancer Educational Content

#BCSM Advances | Optimizing Therapy for HER2+ Disease and Decision Making in Metastatic and Early Stage

Our panel of medical experts – Dr. Reshma Mahtani, Dr. Lee Schwartzberg, and Dr. Sara Tolaney – plus breast cancer patient advocate, Rachel Kilby discuss optimizing therapy for HER2+ disease and decision making in metastatic + early-stage.

Genomic Testing in Early Stage Breast Cancer | Focus on MINDACT from ASCO20

Dr. Reshma Mahtani, from the Sylvester Comprehensive Cancer Center, and Dr. Hope S. Rugo, from the University of California San Francisco, discuss what is changing in genomic testing in early-stage breast cancer with a focus on MINDACT from ASCO 2020.

Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

HER2+ early breast cancer has been revolutionized by the development of HER2 directed therapy, which has significantly reduced breast cancer recurrence risk and improved overall survival. This program is designed to review and discuss the available treatment options for this patient population and discuss how we might individualize therapy in the future to optimize the balance of efficacy and toxicity, review the addition of pertuzumab to a trastuzumab-based adjuvant regimen and discuss improvement of pathologic complete response rates and invasive disease-free survival,  and review the addition of neratinib for patients with high-risk disease and discuss improvement disease-in free survival. 

Optimizing Therapy in HER2+ Disease with Dr. Alvaro Moreno-Aspitia

HER2+ early breast cancer has been revolutionized by the development of HER2 directed therapy, which has significantly reduced breast cancer recurrence risk and improved overall survival. This program is designed to review and discuss the available treatment options for this patient population and discuss how we might individualize therapy in the future to optimize the balance of efficacy and toxicity, review the addition of pertuzumab to a trastuzumab-based adjuvant regimen and discuss improvement of pathologic complete response rates and invasive disease-free survival,  and review the addition of neratinib for patients with high-risk disease and discuss improvement disease-in free survival. 

Optimizing Therapy in HER2+ Disease with Dr. Kevin Kalinsky

HER2+ early breast cancer has been revolutionized by the development of HER2 directed therapy, which has significantly reduced breast cancer recurrence risk and improved overall survival. This program is designed to review and discuss the available treatment options for this patient population and discuss how we might individualize therapy in the future to optimize the balance of efficacy and toxicity, review the addition of pertuzumab to a trastuzumab-based adjuvant regimen and discuss improvement of pathologic complete response rates and invasive disease-free survival,  and review the addition of neratinib for patients with high-risk disease and discuss improvement disease-in free survival. 

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

HER2+ early breast cancer has been revolutionized by the development of HER2 directed therapy, which has significantly reduced breast cancer recurrence risk and improved overall survival. This program is designed to review and discuss the available treatment options for this patient population and discuss how we might individualize therapy in the future to optimize the balance of efficacy and toxicity, review the addition of pertuzumab to a trastuzumab-based adjuvant regimen and discuss improvement of pathologic complete response rates and invasive disease-free survival,  and review the addition of neratinib for patients with high-risk disease and discuss improvement disease-in free survival. 

2020 Updates in Breast Cancer from San Antonio

The Updates from San Antonio meeting will provide clinicians state-of-the-art informatio non breast cancer research with focuses in the study on experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease. The meeting aims to showcase a balance of clinical, translational, and basic research, while providing a forum for concise updates and in-depth discussion and analysis on the latest scientific findings and practice changing advances in breast cancer treatment from the 2019 San Antonio Breast Cancer Symposium.

2020 Best of Breast

The Best of Breast is a new and innovative conference on breast cancer set completely in a multidisciplinary tumor board environment. The world’s leading breast cancer experts will discuss cases beginning with high risk characteristics and take us through to survivorship all the while incorporating data from the major oncologic annual meetings. Expert panelists include breast surgeons, plastic surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, geneticists, psychologists, pharmacists, advanced practitioners, and nurses.
Gastrointestinal Cancer Educational Content

Advances: All About Biology – A Multidisciplinary Med Ed Review of Key GI Updates from ASCO20

This multi- and interdisciplinary educational activity is designed to educate oncologists, surgeons, radiation oncologists and patient advocacy leaders as physician-trainees, pharmacists, nurses, and allied health professionals involved in the care and management of patients with colorectal cancers.

Advances: A Multidisciplinary Med Ed Review of Key GI Updates from ASCO20

This multi- and interdisciplinary educational activity is designed to educate oncologists, surgeons, radiation oncologists and patient advocacy leaders as physician-trainees, pharmacists, nurses, and allied health professionals involved in the care and management of patients with colorectal cancers.

ctDNA and MRD Testing: Emerging Technologies and Clinical Applications

The phenomenon of tumors shedding cell-free DNA into the blood has opened exciting opportunities in cancer diagnosis, monitoring, and treatment. Initial applications have focused on “liquid biopsy”, to identify clinically actionable mutations when tissue is not available. More recently, emerging technologies have enabled the accurate assessment of molecular residual disease (MRD) in solid cancers, to enable patient stratification in the adjuvant setting, treatment response monitoring, and recurrence monitoring. These MRD technologies also promise to transform and disrupt clinical research, by enabling new trial designs enriched for MRD-positive patients and new surrogate endpoints based on MRD clearance. In this event, we will explore the various technologies being used for liquid biopsy and MRD assessment, as well as the data and applications with highest potential utility in clinical practice and research.

Genitourinary Cancer Educational Content
Lung Cancer Educational Content

#LCSM Advances | Immunotherapy and the Adjuvant Use of Osimertinib

Our panel of medical experts – Dr. Millie Das, Dr. Gilberto Lopes, Dr. Shayma Kazmi, and Dr. Ravi Salgia– plus lung cancer patient advocate, Lindi Campbell discuss immunotherapy and the adjuvant use of osimertinib. 

Various Tumor Types Educational Content

2020 Virtual Evolution

Evolution is Changing Paradigms for Women Treating Cancer. It is an innovative virtual conference presented from a female perspective and designed to incorporate sessions on professional and personal wellness.

2020 Virtual ESMO Review

The 2020 Virtual ESMO Review will be a condensed review of the global meeting held earlier in October and will give healthcare providers the opportunity to learn about the latest advances in oncology and translate science into better patient care. This meeting will facilitate the exchange and debate of translational cancer science in a virtual format.

Diversity in Cancer Care

There is a growing appreciation for diversity in the context of equality and equity in medicine. There are far too few educational programs that consider gender, race and ethnicity, and sexual orientation in the development and design of the curriculum, presenters, and intended audiences.

Health care teams should be focused on an inter-professional and interdisciplinary model that values the contributions of a range of perspectives in improving patient outcomes—including patient advocacy stakeholders. This program is designed to elevate and highlight the power of diversity and the goals of equity and equality in the cancer care team and will present both academic and thematic topics.

2020 ASCO Virtual Direct™ Highlights | San Juan

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

2020 ASCO Virtual Direct™ Highlights | San Francisco

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

2020 ASCO Virtual Direct™ Highlights | Las Vegas

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

2020 ASCO Virtual Direct™ Highlights | Philadelphia

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

2020 ASCO Virtual Direct™ Highlights | Denver

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

2020 ASCO Virtual Direct™ Highlights | Jacksonville

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

2020 ASCO Virtual Direct™ Highlights | Boston

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

2020 ASCO Virtual Direct™ Highlights | St. Louis

The 2020 ASCO Virtual Direct™ Highlights condensed the most cutting-edge science and education from the world’s premier oncology event into a two-day virtual program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment from a healthcare team perspective. Expert faculty placed abstract findings into clinical context and discuss how the results may change the current standard of care. 

Cancer Care in the Time of COVID19

Cancer doesn’t stop because of COVID19, and many of the challenges (logistical, psychological, and physical) intensify. The goal of this program is to give insight to help guide healthcare providers in the field of oncology on what to do in this time and to help answer the question, “How can we best care for cancer patients in an uncertain and dangerous healthcare environment?”

2020 West Oncology Conference at Graceland

The 5th Annual West Oncology Conference at Graceland: Advances in the Business and Science of Oncology Special Updates from COA, ASCO, ASH, ASTRO, and ESMO was a valuable forum for the presentation and discussion of new research findings. Participants were provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, head and neck cancers, and lung cancer in a practical and interactive format, fostering discussion and impacting clinical outcomes for patients.

Video Content

Connect with Us:

Total Health Conferencing

20423 State Road 7 F6-496, Boca Raton, FL 33498

Phone: 561-237-2845

Email: info@totalhealthconferencing.com